CED of MTX110 Newly Diagnosed Diffuse Midline Gliomas
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04264143 |
|
Recruitment Status :
Completed
First Posted : February 11, 2020
Last Update Posted : December 18, 2023
|
Sponsor:
Luca Szalontay
Collaborator:
Midatech Pharma US Inc.
Information provided by (Responsible Party):
Luca Szalontay, Columbia University
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | April 25, 2022 |
| Actual Study Completion Date : | November 22, 2023 |